Long-Term Risk of Progression From Unilateral to Bilateral Méniere's Disease: A Systematic Review and Meta-Analysis
- PMID: 40210232
- PMCID: PMC12105955
- DOI: 10.1097/MAO.0000000000004491
Long-Term Risk of Progression From Unilateral to Bilateral Méniere's Disease: A Systematic Review and Meta-Analysis
Abstract
Objective: To evaluate the overall risk of conversion from unilateral to bilateral Méniere's disease (MD), the time interval from initial diagnosis to conversion, and any risk factors or audiometric trends associated with this process.
Databases reviewed: Medline, Embase, Cochrane Library, Scopus, Web of Science, and ClinicalTrials.Gov.
Methods: This review was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies reporting longitudinal progression of unilateral to bilateral MD were included. Random-effects meta-analyses were performed to evaluate the proportion of cases that converted and the mean time to conversion, and a narrative synthesis described risk factors and audiometric data.
Results: A total of 11 studies met the inclusion criteria. For overall conversion risk, meta-analysis of the 9 relevant studies (n = 1583) yielded a risk of 13% (95% CI, 12-15%). Mean time to conversion was 8.2 years (95% CI, 5.9-10.6; I2 = 46%), and a combined Kaplan-Meier analysis revealed a prolonged distribution of conversions including 10% that converted 20 years or later after initial diagnosis. Risk factors and audiometric data were sparsely reported, but there may be a correlation between conversion risk and first-sided ear surgery (protective), history of tympanic membrane perforation, and baseline hearing loss in the unaffected ear.
Conclusion: There is a significant risk of conversion from unilateral to bilateral MD that must be taken into account when considering ablative treatment options, even late into its course. Further work will be required to better characterize risk/protective factors and audiometric trends.
Keywords: Aural vertigo; Bilateral; Endolymphatic hydrops; Intratympanic; Menière; Metachronous; Otogenic vertigo.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of Otology & Neurotology, Inc.
Figures






Similar articles
-
Positive pressure therapy for Ménière's disease or syndrome.Cochrane Database Syst Rev. 2015 Mar 10;2015(3):CD008419. doi: 10.1002/14651858.CD008419.pub2. Cochrane Database Syst Rev. 2015. PMID: 25756795 Free PMC article.
-
Intratympanic corticosteroids for sudden sensorineural hearing loss.Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD008080. doi: 10.1002/14651858.CD008080.pub2. Cochrane Database Syst Rev. 2022. PMID: 35867413 Free PMC article.
-
Surgical interventions for Ménière's disease.Cochrane Database Syst Rev. 2023 Feb 24;2(2):CD015249. doi: 10.1002/14651858.CD015249.pub2. Cochrane Database Syst Rev. 2023. PMID: 36825750 Free PMC article.
-
Systemic pharmacological interventions for Ménière's disease.Cochrane Database Syst Rev. 2023 Feb 23;2(2):CD015171. doi: 10.1002/14651858.CD015171.pub2. Cochrane Database Syst Rev. 2023. PMID: 36827524 Free PMC article.
-
Pharmacologic and surgical therapies for patients with Meniere's disease: A systematic review and network meta-analysis.PLoS One. 2020 Sep 1;15(9):e0237523. doi: 10.1371/journal.pone.0237523. eCollection 2020. PLoS One. 2020. PMID: 32870918 Free PMC article.
References
-
- Sajjadi H, Paparella MM. Meniere's disease. Lancet 2008;372:406–14. - PubMed
-
- Schuknecht HF. Correlation of pathology with symptoms of Meniere's disease. Otolaryngol Clin North Am 1968;1:433–40.
-
- Yamakawa K. Hearing organ of a patient who showed Meniere's symptoms. J Otolaryngol Soc Jpn 1938;44:2310.
-
- Ménière P. Maladie de l'oreille interne offrant les symptomes de la congestion cerebrale apoplectiforme. Gaz med de Paris 1861(s. 3);16:88.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous